These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
6. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner. Lecordier S; Pons V; Rivest S; ElAli A Front Immunol; 2021; 12():813536. PubMed ID: 35173711 [TBL] [Abstract][Full Text] [Related]
7. Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease. Zhong M; Xu QQ; Hu Z; Yang W; Lin ZX; Xian YF J Ethnopharmacol; 2024 Jun; 328():118113. PubMed ID: 38548119 [TBL] [Abstract][Full Text] [Related]
8. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
9. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565 [TBL] [Abstract][Full Text] [Related]
11. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease. Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249 [TBL] [Abstract][Full Text] [Related]
12. Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology. Suelves N; Saleki S; Ibrahim T; Palomares D; Moonen S; Koper MJ; Vrancx C; Vadukul DM; Papadopoulos N; Viceconte N; Claude E; Vandenberghe R; von Arnim CAF; Constantinescu SN; Thal DR; Decottignies A; Kienlen-Campard P Acta Neuropathol Commun; 2023 May; 11(1):82. PubMed ID: 37198698 [TBL] [Abstract][Full Text] [Related]
13. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice. Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055 [TBL] [Abstract][Full Text] [Related]
14. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models. Lantz MJ; Roberts AM; Delgado DD; Nichols RA J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024 [TBL] [Abstract][Full Text] [Related]
15. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance. Gontier G; George C; Chaker Z; Holzenberger M; Aïd S J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229 [TBL] [Abstract][Full Text] [Related]
16. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769 [TBL] [Abstract][Full Text] [Related]
17. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model. Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064 [TBL] [Abstract][Full Text] [Related]
19. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718 [TBL] [Abstract][Full Text] [Related]
20. High-intensity interval training ameliorates Alzheimer's disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization. Feng S; Wu C; Zou P; Deng Q; Chen Z; Li M; Zhu L; Li F; Liu TC; Duan R; Yang L Theranostics; 2023; 13(10):3434-3450. PubMed ID: 37351177 [No Abstract] [Full Text] [Related] [Next] [New Search]